CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ZVRA

Serdexmethylphenidate

Phase 2
ZEVRA THERAPEUTICS, INC. (ZVRA)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Idiopathic Hypersomnia

View Full Landscape
Drug Information

Target Indication

Idiopathic Hypersomnia

Clinical Trial

NCT05668754

Last updated: 1/2/2026

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Jan 25, 2038(11y 5m)

Patents Listed

4

Application

NDA 205489
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.